| Santa Monica Conv Ctr Ii | |
| 2250 29th Street, Santa Monica, California 90405 | |
| (310) 450-7694 | |
| Name | Santa Monica Conv Ctr Ii |
|---|---|
| Location | 2250 29th Street, Santa Monica, California |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 44 |
| Occupancy Rate | 67.73% |
| Medicare ID (CCN) | 055748 |
| Legal Business Name | Ab Crispino & Company Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1376128322 |
| Organization Name | OCEAN PARK HEALTHCARE LLC |
| Address | 2828 Pico Blvd, Santa Monica, CA 90405 |
| Phone Number | 310-450-7694 |
News Archive
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has appointed Antonius Koester, GmbH & Co, KG as its first dental reseller in Germany - and named R+K CAD/CAM Technologie, GmbH & Co., KG, as the first German Authorized Production Center partner.
Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that it has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded accreditation for two years as a provider of continuing medical education for physicians.
The counterfeiting of medicines has been known of since around 1990 and is a growing problem-in both developing and developed countries. Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.
› Verified 3 days ago
| NPI Number | 1457936403 |
| Organization Name | SUNSET PARK HEALTHCARE LLC |
| Address | 2250 29th St, Santa Monica, CA 90405 |
| Phone Number | 310-450-7694 |
News Archive
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has appointed Antonius Koester, GmbH & Co, KG as its first dental reseller in Germany - and named R+K CAD/CAM Technologie, GmbH & Co., KG, as the first German Authorized Production Center partner.
Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that it has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded accreditation for two years as a provider of continuing medical education for physicians.
The counterfeiting of medicines has been known of since around 1990 and is a growing problem-in both developing and developed countries. Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.
› Verified 3 days ago
| NPI Number | 1578649810 |
| Organization Name | AB CRISPINO & COMPANY INC |
| Doing Business As | SANTA MONICA CONVALESCENT CENTER II |
| Address | 2250 29th Street, Santa Monica, CA 90405 |
| Phone Number | 310-450-7694 |
News Archive
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has appointed Antonius Koester, GmbH & Co, KG as its first dental reseller in Germany - and named R+K CAD/CAM Technologie, GmbH & Co., KG, as the first German Authorized Production Center partner.
Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that it has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded accreditation for two years as a provider of continuing medical education for physicians.
The counterfeiting of medicines has been known of since around 1990 and is a growing problem-in both developing and developed countries. Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.
› Verified 3 days ago
| NPI Number | 1699857193 |
| Organization Name | AB CRISPINO & CO. INC |
| Doing Business As | SANTA MONICA CONVALESCENT CENTER I |
| Address | 2828 Pico Blvd, Santa Monica, CA 90405 |
| Phone Number | 310-450-7694 |
News Archive
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has appointed Antonius Koester, GmbH & Co, KG as its first dental reseller in Germany - and named R+K CAD/CAM Technologie, GmbH & Co., KG, as the first German Authorized Production Center partner.
Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that it has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded accreditation for two years as a provider of continuing medical education for physicians.
The counterfeiting of medicines has been known of since around 1990 and is a growing problem-in both developing and developed countries. Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has appointed Antonius Koester, GmbH & Co, KG as its first dental reseller in Germany - and named R+K CAD/CAM Technologie, GmbH & Co., KG, as the first German Authorized Production Center partner.
Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that it has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded accreditation for two years as a provider of continuing medical education for physicians.
The counterfeiting of medicines has been known of since around 1990 and is a growing problem-in both developing and developed countries. Counterfeit medicines are estimated as more than 10% of the global medicines market and in some developing countries it is thought to be as high as 50%. One prediction is that global counterfeit drug sales will reach $75 billion by 2010.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.19 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.97 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.86 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 2.21 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.15 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 29.55 | 14.2 |